Aztreonam-amoxicillin/clavulanate combination therapy against <i>bla</i> NDM-producing Enterobacterales infections
Efrat Orenbuch‐Harroch(Hebrew University of Jerusalem), Jacob Strahilevitz(Hebrew University of Jerusalem), Dan Reshef(Weizmann Institute of Science), Jacob Moran‐Gilad(Ben-Gurion University of the Negev), Violeta Temper(Hebrew University of Jerusalem), Gabriella Snoyman(Hadassah Medical Center), Daniel Grupel(Ben-Gurion University of the Negev), Munther Aqeel Nashashibi(Hadassah Medical Center), Yonatan Oster(Hadassah Medical Center)
Cited by 1
Related Papers
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase
|Nature Medicine|2005|1k
Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat
|Clinical Microbiology Reviews|2009|930
<i>qnr</i> Prevalence in Ceftazidime-Resistant <i>Enterobacteriaceae</i> Isolates from the United States
|Antimicrobial Agents and Chemotherapy|2006|576
Plasmid-Mediated Quinolone Resistance
|Microbiology Spectrum|2014|469
Vaginal microbiome transplantation in women with intractable bacterial vaginosis
|Nature Medicine|2019|411